This compound is a pharmaceutical intermediate specifically used in the manufacture of ledipasvir, an antiviral agent. It is a stereochemically defined molecule containing multiple aromatic rings, halogen atoms, and a spirocyclic amine structure.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1256388-49-4
(S)-tert-butyl 6-(5-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-1H-iMidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate
Pharmaceutical intermediate for antiviral synthesis
Tert-butyl (1R,3S,4S)-3-(6-bromo-1H-benzimidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate
Ledipasvir intermediate
Carbamic acid, N-[(1S)-1-[[(6S)-6-[5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]-, methyl ester
Pharmaceutical intermediate
Ledipasvir Intermediate
Pharmaceutical intermediate for ledipasvir
2-methyl-2-(4-vinylphenyl)propanoic acid
Pharmaceutical intermediate
2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid
Pharmaceutical intermediate
benzyl (6S)-6-[5-(7-bromo-9,9-difluorofluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylate
HTUJXNNBCXWTGU-SANMLTNESA-N
C1CC12C[C@H](N(C2)C(=O)OCC3=CC=CC=C3)C4=NC=C(N4)C5=CC6=C(C=C5)C7=C(C6(F)F)C=C(C=C7)Br
—